White House Pushes AI Breakthroughs to Cure Kids' Cancer Faster
Published Date: 10/7/2025
Presidential Document
Summary
The President is launching a bold plan to use artificial intelligence (AI) to fight pediatric cancer, the top disease killer of kids aged 1-19 in the U.S. This builds on a $50 million yearly investment in childhood cancer data and aims to speed up new cures, better treatments, and early diagnosis. Families, researchers, and healthcare systems will see faster progress starting now, with strong privacy protections in place.
Analyzed Economic Effects
8 provisions identified: 8 benefits, 0 costs, 0 mixed.
AI to Improve Predictive Models and Biomarkers
The order prioritizes using AI tools to analyze complex biological data to improve predictive modeling of patient response, disease progression, and treatment toxicity, and to turn multi-omics and imaging data into new diagnostic and therapeutic biomarkers. The stated goal is earlier and superior diagnostics and treatments.
Existing $50M/Year Childhood Cancer Fund
The order builds on the Childhood Cancer Data Initiative (CCDI), a Federal investment of $50 million every year for 10 years that began in 2019. This funding supports data collection and research that the Administration says will help speed pediatric cancer discoveries.
Federal Push to Increase Pediatric Cancer Funding
The MAHA Commission and federal agencies are directed to prioritize identifying and implementing strategies to increase investment from existing Federal funds for the CCDI and other Federal initiatives that address pediatric cancer. The order explicitly instructs agencies to prioritize expanding research and care investments.
Data Platforms and NCI Research Funding
The order directs making data platforms and tools available as part of the CCDI Data Ecosystem and funding research projects at National Cancer Institute-Designated Cancer Centers. These steps are aimed at accelerating AI-driven solutions for pediatric cancer.
Consolidating Data for AI-Ready Trials
The order directs improving data infrastructure by consolidating data from multiple sources for AI-ready analysis and using AI to better select participants for clinical trials. The aim is to make trial recruitment and participant selection more effective.
AI to Improve Clinical Trial Access and Outcomes
The order directs use of multimodal data and AI approaches to improve clinical trial design, accessibility, recruitment, administration, conduct, and interpretation of results to improve outcomes for patients. The goal is better trial access and more useful trial results.
Patient Control and Interoperability Standards
The Secretary, in consultation with the Assistant to the President for Science and Technology, is directed to finalize interoperability standards for patient data used with AI and to ensure patients and parents control their health information. The aim is safe, privacy-compliant exchanges that include structured and unstructured data.
Encouraging Private Sector AI Engagement
The order instructs agencies to encourage the private sector to use advanced technologies, including AI, to help unlock cures for pediatric cancer to the maximum possible extent. This is an explicit call for private-sector engagement in pediatric cancer innovation.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in